Trials / Completed
CompletedNCT00191022
Comparison of LY686017 With a Marketed Drug in the Treatment of Social Anxiety Disorder
A Randomized, Double-Blind Comparison of LY686017, Paroxetine, and Placebo in the Treatment of Social Anxiety Disorder
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 185 (planned)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study is a Phase 2 trial to test the efficacy of LY686017 in the treatment of Social Anxiety Disorder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LY686017 | |
| DRUG | paroxetine | |
| DRUG | placebo |
Timeline
- Start date
- 2004-12-01
- Completion
- 2007-01-01
- First posted
- 2005-09-19
- Last updated
- 2007-02-13
Locations
15 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00191022. Inclusion in this directory is not an endorsement.